Velichka Valcheva

CNS pipeline · person

Velichka Valcheva, MD, MSc

Chief Executive Officer of GH Research since September 2024, having previously served as Chief Medical Officer (from February 2024) and VP of Clinical Research and Medical Affairs (from August 2023). More than 20 years in pharma/biotech leadership, including Head of Medical Affairs International at Albireo and Global Senior Medical Director Oncology at Ipsen. Holds a Dr. Med. from the University of Medicine, Plovdiv and a Masters in Pharmaceutical Medicine from Trinity College Dublin.

  • 1 company

Courtesy GH Research

Current roles

Appears with

People sharing a company with Velichka.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.